Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  PeptiDream Inc.    4587   JP3836750004

PEPTIDREAM INC.

(4587)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
5920 5830 5910 5760 5860 Last
474200 365600 248600 428900 297900 Volume
-1.17% -1.52% +1.37% -2.54% +1.74% Change
Financials
Sales 2020 11 828 M 113 M 113 M
Net income 2020 4 606 M 44,1 M 44,1 M
Net cash position 2020 7 567 M 72,5 M 72,5 M
P/E ratio 2020 160x
Yield 2020 -
Sales 2021 15 336 M 147 M 147 M
Net income 2021 6 832 M 65,5 M 65,5 M
Net cash position 2021 11 615 M 111 M 111 M
P/E ratio 2021 117x
Yield 2021 0,05%
Capitalization 737 B 7 079 M 7 061 M
EV / Sales 2020 61,6x
EV / Sales 2021 47,3x
Nbr of Employees 123
Free-Float 74,2%
More Financials
Company
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and... 
More about the company
Notations Surperformance© of PeptiDream Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PEPTIDREAM INC.
01/04PEPTIDREAM : Partner Kleo Pharmaceuticals to Merge with NYSE-Listed Biohaven Pha..
MT
2020PEPTIDREAM : Licenses Peptide Discovery Platform System to Belgian Pharma Compan..
MT
2020PEPTIDREAM : Takeda Ink Research, License Agreement for Neuromuscular Disease Dr..
MT
2020Peptidream to Work Together with French Amolyt Pharma on Acromegaly Treatment..
MT
2020MARKET CHATTER : Peptidream-Janssen Pharmaceuticals Alliance Achieves Developmen..
MT
2020Peptidream and Four Others Establish Joint Venture to Develop COVID-19 Treati..
MT
2020Japan's Fujitsu, Mizuho, PeptiDream to form joint venture to develop COVID-19..
RE
2020PEPTIDREAM : Kleo Pharmaceuticals Presents Preclinical Proof-of-Concept Data on ..
AQ
2020FUJITSU : and PeptiDream Achieve Milestone in Joint Research for Peptide Drug Ca..
AQ
2020PEPTIDREAM : Our approach to sustainability(esg)
PU
2020PEPTIDREAM : Corporate Governance Report 07/08/2020
PU
2020PEPTIDREAM : Non-consolidated Financial Results for the Six Months Ended June 30..
PU
2020Japan's PeptiDream to work with Merck in developing COVID-19 therapies
RE
2019Muddy Waters rebukes Japan, French efforts to rein in short sales
RE
2019Japan pension giant's war on short sellers will have only limited effect - an..
RE
More news
News in other languages on PEPTIDREAM INC.
2019Muddy Waters éclabousse NMC Health
2015SANOFI : et PeptiDream s'associent pour développer des peptides thérapeutiques
2013IPSEN : renforce son partenariat avec PeptiDream dans les maladies endocrinienne..
More news
Chart PEPTIDREAM INC.
Duration : Period :
PeptiDream Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PEPTIDREAM INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 5 860,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Patrick Crawford Reid President & Representative Director
Kiichi Kubota Chairman
Keiichi Masuya Director, Manager-Research & Development
Hiroaki Suga Outside Director
Michio Sasaoka Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
PEPTIDREAM INC.12.79%6 985
GILEAD SCIENCES, INC.12.39%83 610
WUXI APPTEC CO., LTD.36.65%64 891
VERTEX PHARMACEUTICALS-4.69%61 795
REGENERON PHARMACEUTICALS6.72%57 427
BEIGENE, LTD.24.12%32 675